An optimized growth factor cocktail for ovine mesenchymal stem cells

Growth Factors

Volumn 30, Issue 1, 2012, Pages 37-48

  Somers, Pamela ^a   Cornelissen, Ria ^a   Thierens, Hubert ^a   Van Nooten, Guido ^b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Growth factors; Invasion; Mesenchymal stem cells; Migration; Proliferation; Tissue engineering

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AB; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; HEART VALVE; IN VITRO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; SHEEP; TISSUE ENGINEERING;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEART VALVES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELLS; SHEEP, DOMESTIC; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA;

OVIS;

EID: 84855860359     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2011.634411     Document Type: Article

References (35)

1. Amado LC, Saliaris AP, Schuleri KH, St JohnM, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW. 2005. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102(32):11474-11479. (Pubitemid 41153844)
2. An C, Cheng Y, Yuan Q, Li J. 2010. IGF-1 and BMP-2 induces differentiation of adipose-derived esenchymal stem cells into chondrocyte-like cells. Ann Biomed Eng 38(4):1647-1654.
3. Antala A. 2007. Engineering tissues, organs and cells. J Tissue Eng Regen Med 1:83-96.
4. Assis C, Carvalho JL, Jacoby BA, Ferreira RL, Castanheira P, Diniz SO, Cardoso VN, Goes AM, Ferreira AJ. 2010. Timedependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart. Cell Transplant 19:219-230.
5. Baraki H,Tudorache I, BraunM, Hö fferK,GörlerA,LichtenbergA, Bara C, Calistru A, Brandes G, Hewicker-Trautwein M, HilfikerA,HaverichA, Cebotari S. 2009.Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model. Biomaterials 30(31):6240-6246.
6. BingerT, Stich S,Andreas S, Kaps C, SezerO,NotterM, SittingerM, Ringe J. 2009. Migration potential and gene expression profile of humanmesenchymal stem cells induced by CCL25. Exp Cell Res 315(8):1468-1479.
7. Bocchi L, Savi M, Graiani G, Rossi S, Agnetti A, Stillitano F, Lagastra C, Baruffi S, Berni R, Frati C, Vassalle M, Squarcia U, Cerbai E, Macchi E. 2011. Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction. PloS One 6(3):e177750.
8. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M. 2001. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32: 1005-1011. (Pubitemid 32285175)
9. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315-317.
10. Fuchs JR, Hannouche D, Terada S, Zand S, Vacanti JP, Fauza DO. 2005. Cartilage engineering from ovine umbilical cord blood mesenchymal progenitor cells. Stem Cells 23:958-964. (Pubitemid 41170951)
11. Grayson WL, Ma T, Bunnell B. 2004. Human mesenchymal stem cells tissue development in 3D PET matrices. Biotechnol Prog 20:905-912. (Pubitemid 38784031)
12. Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. 2003. Molecular and cellular characterisation of highly purified stromal cells derived from human bone marrow. J Cell Sci 116(9):1827-1835. (Pubitemid 36582169)
13. Hamamoto H, Gorman JH, Ryan LP, Hinmon R, Martens TP, Schuster MD, Plappert T, Kiupel M, St John-Sutton MG, Itescu S, Gorman RC. 2009. Allogeneic mesenchymal progenitor cell therapy to limit remodeling after myocardial infarction: The effect of cell dosage. Ann Thorac Surg 87(3):794-801.
14. Jager M, Bachmann R, Scharfstadt A, Krauspe R. 2006. Ovine cord blood accommodates multipotent mesenchymal progenitor cells. In Vivo 20:205-214.
15. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. 1998. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238:265-272. (Pubitemid 28366150)
16. Jorgensen C, Gordeladze J, Noel D. 2004. Tissue engineering through autologous mesenchymal stem cells. Curr Opin Biotechnol 15:406-410. (Pubitemid 39304035)
17. Kim H, Kim U, Vunjak-Novakovic G, Min B, Kaplan DL. 2005. Influence of macroporous protein scaffolds on bone tissue engineering from bone marrow stem cells. Biomaterials 26: 4442-4452. (Pubitemid 40208605)
18. Kratchmarova I, Blagoev B, Haack-Sorensen M, Kassem M, Mann M. 2005. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308:1472-1477. (Pubitemid 40791302)
19. Krause U, Harter C, Seckinger A, Wolf D, Reinhard A, Bea F, Dengler T, Hardt S, Ho A, Katus HA, Kuecherer H, Hansen A. 2007. Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart. Stem Cells Dev 16(1):31-37. (Pubitemid 46362590)
20. McCarty RC, Gronthos S, Zannettino AC, Foster BK, Xian CJ. 2009. Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells. J Cell Physiol 219:324-333.
21. Miller ED, Li K, Kanade T, Weiss LE, Walker LM, Campbell PG. 2011. Spatially directed guidance of stem cell population migration by immobilized patterns of growth factors. Biomaterials 32(11):2775-2785.
22. Mrugala D, Bony C, Neves N, Caillot L, Fabre S, Moukoko D, Jorgensen C, Noël D. 2008. Phenotypic and functional characterization of ovine mesenchymal stem cells: Application to a cartilage defect model. Ann Rheum Dis 67:288-295. (Pubitemid 351281260)
23. Narine K, DeWeverO, Van ValckenborghD, Francois K, Bracke M, De Smet S, Mareel M, Van Nooten G. 2006. Growth factor modulation of fibroblast proliferation, differentiation, and invasion: Implications for tissue valve engineering. Tissue Eng 12(10):2707-2716. (Pubitemid 46141239)
24. Perin EC, SilvaGV, Assad JA, VelaD, Buja LM, Sousa AL, Litovsky S, Lin J, VaughnWK, Coulter S, FernandesMR, Willerson JT. 2008. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a caninemodel of acutemyocardial infarction. J Mol Cell Cardiol 44(3):486-495. (Pubitemid 351374698)
25. Perry TE, Kaushal S, Sutherland FW, Guleserian KJ, Bischoff J, Sacks M, Mayer JE. 2003. Thoracic surgery directors association award. Bone marrow as a cell source for tissue engineering heartvalves. Ann thorac Surg 75(3):761-767. (Pubitemid 36298336)
26. Ponte AL, Marais E, Gallay N, Langonné A, Delorme B, Hérault O, Charbord P, Domenech J. 2007. The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells 25(7):1737-1745. (Pubitemid 47121852)
27. Schenk S, Mal N, Finan M, Zhang M, Kiedrowki Z, Popovic P, McCarthy M, Penn MS. 2007. Monocyte chemotactic protein-3 is a myocardia mesenchymal stem cell homing factor. Stem Cells 25:245-251. (Pubitemid 46052996)
28. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ. 2005. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model.Circulation 111(2):150-156. (Pubitemid 40139725)
29. Somers P, Narine K, De Somer F, De Vos F, Van Nooten G. 2008. Sustained release and activation of the growth factor basic fibroblast growth factor from loaded scaffolds in heart valve tissue engineering. Growth Factors 26(5):293-299.
30. Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F. 2008. Inflammation and tumor microenvironments: Defining the migratory itinerary of mesenchymal stem cells. Gene Ther 15(10):730-738. (Pubitemid 351627356)
31. Van Nooten G, Somers P, Cornelissen M, Bouchez S, Gasthuys F, Cox E, Sparks L, Narine K. 2006. Acellular porcine and kangaroo aortic valve scaffolds show more intense immunemediated calcification than cross-linked Toronto SPV valves in the sheep model. Interact Cardiovasc Thorac Surg 5(5): 544-549. (Pubitemid 44504065)
32. Vesely I. 2005. Heart valve tissue engineering. Circ Res 97: 743-755. (Pubitemid 41447124)
33. Vincentelli A, Wautot F, Juthier F, Fouquet O, Corseaux D, Marechaux S, Le Toutneau T, Fabre O, Susen S, Van Belle E, Mouquet F, Decoene C, Prat A, Jude B. 2007. In vivo autologous recellularization of a tissue-engineered heart valve: Are bone marrow mesenchymal stem cells the best candidates? J Thorac Cardiovasc Surg 134:424-432. (Pubitemid 47088619)
34. Wang Q, McGoron AJ, Kato Y, Pinchuk L, Schoephoerster RT. 2010. In-vivo assessment of a novel polymer (SIBS) trileaflet heart valve. J Heart Valve Dis 19(4):499-505.
35. Wang JJ, Ye F, Cheng LJ, Shi YJ, Bao J, Sun HQ,WangW, Zhang P, Bu H. 2009. Osteogenic differentiation of mesenchymal stem cells promoted by overexpression of connective tissue growth factor. J Zhejiang Univ Sci B 10(5):355-367.